These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7600566)

  • 1. Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative. I. Meth A tumor eradication and tumor-neutralizing activity in mice pretreated with ZSS or NCS.
    Masuda E; Maeda H
    Cancer Immunol Immunother; 1995 May; 40(5):329-38. PubMed ID: 7600566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
    Masuda E; Maeda H
    Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
    Numasaki Y; Takahashi K; Masuda E; Nohara C; Maeda H
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2289-94. PubMed ID: 1834021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
    Schmitt DA; Kisanuki K; Kimura S; Oka K; Pollard RB; Maeda H; Suzuki F
    Anticancer Res; 1992; 12(6B):2219-24. PubMed ID: 1295469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M; Konno T; Ohtsuka N; Mizumachi R; Oda T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
    Kimoto A; Konno T; Kawaguchi T; Miyauchi Y; Maeda H
    Cancer Res; 1992 Feb; 52(4):1013-7. PubMed ID: 1531320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
    Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].
    Oda T; Konno T; Ohtsuka N; Kimura M; Mizumachi R
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2423-8. PubMed ID: 1835341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.
    Suzuki F; Pollard RB; Maeda H
    Cancer Immunol Immunother; 1989; 30(2):97-104. PubMed ID: 2480846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cellular composition induced by neocarzinostatin pretreatment in Meth A-bearing mice and the responsible antitumor effector cells.
    Masuda E; Shishido T; Fujimoto R; Maeda H
    Immunopharmacology; 1997 Aug; 37(1):105-16. PubMed ID: 9285249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase I study of YM881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Research Group for Intra-arterial Infusion Therapy with YM881].
    Taguchi T; Saito T; Ota J; Nakao I; Ohashi K; Nakamura H; Konno T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1657-63. PubMed ID: 1651686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
    Abe S; Otsuki M
    Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):715-26. PubMed ID: 12678722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor mechanisms of zinostatin stimalamer (YM881).
    Tanaka S; Yamamoto M; Numasaki Y
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
    Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
    Maeda H
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):169-85. PubMed ID: 11259839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.
    Ikeda K; Saitoh S; Suzuki Y; Tsubota A; Koida I; Kobayashi M; Arase Y; Chayama K; Murashima N; Kumada H
    J Gastroenterol; 1997 Aug; 32(4):513-20. PubMed ID: 9250900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action mechanisms of zinostatin stimalamer (YM881)].
    Tanaka S; Numasaki Y; Maeda H
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2295-300. PubMed ID: 1834022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the intra-tumor tissue concentration of zinostatin stimalamer in the liver following intra-arterial injection of zinostatin stimalamer (YM881) suspension].
    Toge T; Jinushi K; Sawamura A; Matsuki K
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1677-80. PubMed ID: 1651687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of hepatic arterial infusion chemotherapy with zinostatin stimalamer alone for hepatocellular carcinoma.
    Ishii H; Furuse J; Nagase M; Maru Y; Yoshino M; Hayashi T
    Jpn J Clin Oncol; 2003 Nov; 33(11):570-3. PubMed ID: 14711981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.
    Oda T; Yamamoto H; Miki T; Maeda H
    Jpn J Cancer Res; 1989 Apr; 80(4):394-9. PubMed ID: 2526108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.